drugset / Trial / NCT00011895

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00011895 ↗

Phase 4 Unknown 400 enrolled GlaxoSmithKline
Treatment

Summary

The purpose of this study is to determine the effect of treatment with Trizivir (TZV) plus efavirenz (EFV) or TZV alone on viral load (level of HIV in the blood).

Timeline

Start
2001-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified — —
Subject Efavirenz Other / unclassified — —
Subject Lamivudine Other / unclassified — —
Subject Zidovudine Small molecule — —